Cardiosense reposted this
Hey Chicago - join us for a deep-dive conversation on A.I. in cardio care with Meesha Dogan, PhD, founder and CEO of Cardio Diagnostics Holdings Inc., and Amit Gupta, founder and CEO of Cardiosense. Meesha and Amit will join Portal’s Director of Venture Operations, Steven Lehmann in a conversation about monitoring, predicting, and measuring cardiac health and some of the awesome possibilities coming to market now. Register for the event here: https://lnkd.in/gBsZFUJW
We are proud to announce that Cardiosense has been awarded the "Best IoT Healthcare Wearable Device" in the 2024 MedTech Breakthrough Awards! This recognition underscores our commitment to advancing virtual cardiac care by developing novel, multi-modal sensors and advanced machine learning algorithms to detect early signs of cardiac disease and guide personalized therapy. A heartfelt thank you to our dedicated team and partners who share our vision for combatting preventable cardiac disease. Congratulations to all the amazing winners! https://cardiosense.com/
🎉 Exciting news from the world of digital health and medical technology innovation! 🏥 We’re thrilled to officially announce the results of our 8th annual MedTech Breakthrough Awards program. 🌟 This year's awards highlight the best and brightest in categories ranging from Patient Engagement to Medical Devices, showcasing the incredible impact of breakthrough new technology on patient care, clinical operations, and overall healthcare outcomes. To all of our 2024 MedTech Breakthrough Award winners - Your innovative spirit and dedication to excellence are driving transformative advancements that are reshaping the healthcare industry for the better. Congratulations, and here's to continued success and impact! 🚀 https://lnkd.in/gbg4fHRd #MedTechBreakthrough #HealthcareInnovation #DigitalHealth #MedTech
HF is the leading cause of hospitalization among older adults and Medicare beneficiaries with HF have the highest readmission rate of any condition. It's estimated that nearly half of these hospitalizations can be avoided by optimizing outpatient therapy. Come join our mission in combatting preventable cardiac disease: https://lnkd.in/gdiGTFpi #HFWeek2024
Heart Failure (HF) patients have a 20% chance of landing back in the hospital within their first 30 days of being discharged. To learn more about HF and the research being done to improve the lives of those affected, follow us and visit our website at cardiosense.com #HFWeek2024
Did you know? 1 in 4 individuals will face the challenge of heart failure in their lifetime. At Cardiosense, we're dedicated to changing this statistic through innovative healthcare solutions. Stay tuned by following us on Linkedin and visiting our website: cardiosense.com #HFWeek2024
Heart Failure (HF) is a growing problem in the United States and around the world. If you'd like to learn more about HF, follow us for more insights and explore our work further on our website: cardiosense.com #HFWeek2024
This year's theme of Heart Failure (HF) Awareness Week is "Heartbeat of Research". Here at Cardiosense, we are dedicated to improving the lives of those affected by HF through groundbreaking technology backed by decades of research from the top minds in the field. Follow us to stay up to date on our journey and learn more at our website: cardiosense.com #HFWeek2024
Proud to announce that Cardiosense won the Science Pitch at the American Heart Association Center for Health Technology (CHTI) Health Technology Competition at #AHA23. Well done Amit Gupta and Omer Inan and the entire Cardiosense team that have helped along the way! And congratulations to all the participants. It was a blast learning about all of the exciting technologies coming to cardiology!
Accomplished Board Member | Expert healthcare industry knowledge from scientific and commercial perspectives
2wLooks like a great event! I'm headed out of town that day for a long weekend, unfortunately.